Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva Pharmaceuticals USA Inc.

www.tevausa.com

Latest From Teva Pharmaceuticals USA Inc.

Tentative Biosimilar Approvals Under Consideration By FDA

Concept could help sponsors who reach approvability but must wait several years before reference product exclusivity expires.

Biosimilars Regulation

Can Biosimilars Compete With ‘Unbranded Biologics’ In The US Market?

Biologics with their brand name dropped from the label could become the alternative to an ‘authorized biosimilar,’ which is not allowed under the law.

Biosimilars Review Pathway

Tentative Biosimilar Approvals A Consideration for the US FDA

Concept could help sponsors who reach approvability but must wait several years before reference product exclusivity expires.

Biosimilars Review Pathway

When You Can’t Win For Losing: Kodak And The Reshoring Of US Pharmaceutical Manufacturing

Kodak, Fujifilm and startups Civica Rx and Phlow fight with grit, vision and government support to restore US pharmaceutical manufacturing.

Business Strategies Ingredients
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
UsernamePublicRestriction

Register